Identification of Free-B-Ring flavonoids as potent COX-2 inhibitors
EP1855528A2
Formulation of a mixture of free-b-ring flavonoids and flavans as a therapeutic agent
TW200630102A
Formulation of dual eicosanoid system and cytokine system inhibitors for use in the prevention and treatment of oral diseases and conditions
CN103356514A
Diarylalkanes as potent inhibitors of binuclear enzymes
US2005124703A1
Polycosanols from Ericerus pela wax
BRPI0406279A
formulation of a mixture of free ring-b-flavonoids and flavanes as a therapeutic agent
KR20070030160A
Formulation of a mixture of free-b-ring flavonoids and flavans for use in the prevention and treatment of cognitive decline and age-related memory impairments
CN1753681A
Be used to prevent and treat compositions by inductive disease of sugar and disease
CA2703698A1
Formulation of a mixture of free-b-ring flavonoids and flavans as a therapeutic agent
US6683116B1
Polycosanols from Ericerus pela wax
US2003113797A1
Method for generating, screening and dereplicating natural product libraries for the discovery of therapeutic agents
US6884783B2
7-Hydroxy chromones as potent antioxidants
US2003180402A1
Isolation of a dual cox-2 and 5-lipoxygenase inhibitor from acacia
US2003165588A1
Identification of free-B-ring flavonoids as potent COX-2 inhibitors
US6451357B1
Method for purification of aloesin
EP0817636A1
Cinnamoyl-c-glycoside chromone isolated from aloe barbadensis
